CCIA
TMO icon

Campbell & Co Investment Adviser’s Thermo Fisher Scientific TMO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.15M Buy
16,256
+8,808
+118% +$4.23M 0.43% 21
2026
Q1 		$3.66M Buy
7,448
+2,290
+44% +$1.24M 0.21% 132
2025
Q4 		$2.99M Buy
+5,158
New +$2.92M 0.14% 214
2025
Q3 		– Sell
-2,892
Closed -$1.17M – 1382
2025
Q2 		$1.17M Buy
+2,892
New +$1.21M 0.07% 438
2024
Q3 		– Sell
-4,781
Closed -$2.64M – 1332
2024
Q2 		$2.64M Buy
+4,781
New +$2.74M 0.22% 102
2024
Q1 		– Sell
-720
Closed -$382K – 1367
2023
Q4 		$382K Buy
+720
New +$349K 0.03% 830
2023
Q3 		– Sell
-657
Closed -$343K – 1196
2023
Q2 		$343K Buy
+657
New +$355K 0.06% 600
2021
Q4 		– Sell
-400
Closed -$229K – 819
2021
Q3 		$229K Sell
400
-300
-43% -$165K 0.07% 468
2021
Q2 		$353K Buy
700
+100
+17% +$47.2K 0.15% 262
2021
Q1 		$274K Sell
600
-900
-60% -$430K 0.17% 255
2020
Q4 		$699K Buy
+1,500
New +$703K 0.43% 41
2020
Q1 		– Sell
-3,650
Closed -$1.19M – 484
2019
Q4 		$1.19M Buy
+3,650
New +$1.11M 0.36% 36
2018
Q4 		– Sell
-2,571
Closed -$628K – 504
2018
Q3 		$628K Buy
2,571
+1,200
+88% +$276K 0.43% 47
2018
Q2 		$284K Buy
+1,371
New +$291K 0.22% 214
2018
Q1 		– Sell
-1,471
Closed -$279K – 526
2017
Q4 		$279K Buy
+1,471
New +$282K 0.21% 207
2017
Q3 		– Sell
-7,459
Closed -$1.3M – 458
2017
Q2 		$1.3M Buy
7,459
+3,961
+113% +$665K 1.21% 4
2017
Q1 		$537K Buy
3,498
+1,110
+46% +$170K 1.39% 2
2016
Q4 		$337K Buy
+2,388
New +$352K 1.04% 21
2014
Q2 		– Sell
-25,240
Closed -$3.04M – 238
2014
Q1 		$3.04M Buy
+25,240
New +$3M 1.22% 25

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Campbell & Co Investment Adviser's TMO Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Thermo Fisher Scientific (TMO) stake by 118% in Q2 2026, buying an estimated $4.23M and bringing the position to 16,256 shares worth $8.15M. The position accounts for 0.43% of the portfolio, ranked #21.

Campbell & Co Investment Adviser first reported a position in TMO in Q1 2014 and has held it in 19 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Campbell & Co Investment Adviser held 16,256 shares of Thermo Fisher Scientific worth $8.15M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 8,808 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.23M.
  • Thermo Fisher Scientific made up 0.43% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #21 holding.
  • Campbell & Co Investment Adviser first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 19 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.